Literature DB >> 33144442

The Systemic Immune-Inflammation Index Predicts Clinical Outcomes in Kidney Transplant Recipients.

Samantha E Halpern1, Dimitrios Moris2, Brian I Shaw3, Madison K Krischak1, Danae G Olaso1, Samuel J Kesseli3, Kadiyala Ravindra3, Lisa M McElroy3, Andrew S Barbas3.   

Abstract

BACKGROUND: Outcomes after kidney transplantation (KTx) remain limited by delayed graft function (DGF) and acute rejection. Non-invasive biomarkers may help identify patients at increased risk for these events. We examined the association between the systemic immune-inflammation index (SII), a novel inflammatory biomarker, and outcomes after KTx and evaluated its ability to predict post-transplant prognosis. PATIENTS AND METHODS: Adult patients who underwent primary KTx at our institution between 2016-2019 were included. SII was calculated from pre-transplant complete blood counts as the ratio of the neutrophil count to the lymphocyte count multiplied by the platelet count. The cutoff between high and low SII was determined by maximizing the area under the curve. Multivariable logistic and Cox regression were used to identify factors associated with DGF and patient, rejection-free, and graft survival respectively.
RESULTS: Overall, 378 KTx recipients were included; 224 (59.3%) had high SII. On unadjusted analysis, high SII was associated with reduced odds of DGF, and improved patient and rejection-free survival. After adjustment, high SII was independently associated with improved patient survival alone. Multivariable models incorporating SII performed well for the prediction of DGF (c-statistic=0.755) and patient survival (c-statistic=0.786), though rejection-free survival was more difficult to predict (c-statistic=0.635).
CONCLUSION: SII demonstrated limited utility as an independent predictor of outcomes after KTx. However, in combination with other clinically relevant parameters, SII is a useful predictor of post-KTx prognosis. Validation of this novel inflammatory biomarker in a multi-institutional study is needed to further elucidate its practical applications in transplantation. Copyright
© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Systemic immune-inflammation index; acute rejection; biomarkers; delayed graft function; kidney transplantation

Mesh:

Year:  2020        PMID: 33144442      PMCID: PMC7811637          DOI: 10.21873/invivo.12173

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  32 in total

1.  Platelet to Lymphocyte Ratio in Cardiovascular Diseases: A Systematic Review.

Authors:  Alparslan Kurtul; Ender Ornek
Journal:  Angiology       Date:  2019-04-28       Impact factor: 3.619

Review 2.  Biomarkers of rejection in kidney transplantation.

Authors:  Neeraj Singh; Hrishikesh Samant; Alan Hawxby; Millie D Samaniego
Journal:  Curr Opin Organ Transplant       Date:  2019-02       Impact factor: 2.640

3.  Predictors and outcomes of delayed graft function after living-donor kidney transplantation.

Authors:  Robert R Redfield; Joseph R Scalea; Tiffany J Zens; Brenda Muth; Dixon B Kaufman; Arjang Djamali; Brad C Astor; Maha Mohamed
Journal:  Transpl Int       Date:  2015-10-26       Impact factor: 3.782

4.  Pre-transplant immune state defined by serum markers and alloreactivity predicts acute rejection after living donor kidney transplantation.

Authors:  Florian W R Vondran; Kai Timrott; Sonja Kollrich; Ann-Kristin Steinhoff; Alexander Kaltenborn; Harald Schrem; Juergen Klempnauer; Frank Lehner; Reinhard Schwinzer
Journal:  Clin Transplant       Date:  2014-07-22       Impact factor: 2.863

5.  Systemic Immune-Inflammation Index (SII) is Useful to Predict Survival Outcomes in Patients After Liver Transplantation for Hepatocellular Carcinoma within Hangzhou Criteria.

Authors:  Hongyuan Fu; Jun Zheng; Jianye Cai; Kaining Zeng; Jia Yao; Liang Chen; Hui Li; Jiebin Zhang; Yingcai Zhang; Hui Zhao; Yang Yang
Journal:  Cell Physiol Biochem       Date:  2018-05-11

6.  Neutrophil-lymphocyte ratio and creatinine reduction ratio predict good early graft function among adult cadaveric donor renal transplant recipients. Single institution series.

Authors:  Piotr Hogendorf; Anna Suska; Aleksander Skulimowski; Joanna Rut; Monika Grochowska; Aleksandra Wencel; Filip Dziwisz; Michał Nowicki; Dariusz Szymański; Grażyna Poznańska; Adam Durczyński; Janusz Strzelczyk
Journal:  Pol Przegl Chir       Date:  2018-04-30

7.  OPTN/SRTR 2018 Annual Data Report: Kidney.

Authors:  A Hart; J M Smith; M A Skeans; S K Gustafson; A R Wilk; S Castro; J Foutz; J L Wainright; J J Snyder; B L Kasiske; A K Israni
Journal:  Am J Transplant       Date:  2020-01       Impact factor: 8.086

Review 8.  Delayed graft function in kidney transplantation.

Authors:  Norberto Perico; Dario Cattaneo; Mohamed H Sayegh; Giuseppe Remuzzi
Journal:  Lancet       Date:  2004 Nov 13-19       Impact factor: 79.321

9.  Average values and racial differences of neutrophil lymphocyte ratio among a nationally representative sample of United States subjects.

Authors:  Basem Azab; Marlene Camacho-Rivera; Emanuela Taioli
Journal:  PLoS One       Date:  2014-11-06       Impact factor: 3.240

10.  The systemic immune-inflammation index predicts prognosis in intrahepatic cholangiocarcinoma: an international multi-institutional analysis.

Authors:  Diamantis I Tsilimigras; Dimitrios Moris; Rittal Mehta; Anghela Z Paredes; Kota Sahara; Alfredo Guglielmi; Luca Aldrighetti; Matthew Weiss; Todd W Bauer; Sorin Alexandrescu; George A Poultsides; Shishir K Maithel; Hugo P Marques; Guillaume Martel; Carlo Pulitano; Feng Shen; Olivier Soubrane; Bas G Koerkamp; Itaru Endo; Timothy M Pawlik
Journal:  HPB (Oxford)       Date:  2020-04-04       Impact factor: 3.647

View more
  1 in total

1.  Systemic Immune-Inflammation Index Is Associated With Increased Urinary Albumin Excretion: A Population-Based Study.

Authors:  Zheng Qin; Hancong Li; Liya Wang; Jiwen Geng; Qinbo Yang; Baihai Su; Ruoxi Liao
Journal:  Front Immunol       Date:  2022-03-21       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.